Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
about
Recent advances in primary Sjogren's syndromeHigh-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data from the TEARS Randomized Trial.Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureLymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.Present and future of biologic drugs in primary Sjögren's syndrome.Autoimmunity in 2016.Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Current perspective on rituximab in rheumatic diseases.Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
P2860
Q26747049-0A901EF9-9FCD-4367-9C91-75ADB006F6A8Q30372606-961A9900-D87C-45A0-9CD0-089C134E8540Q36070691-4EBE7700-3215-4BE1-8A4F-88AEADF739C0Q36481706-D1EF6719-EB9A-4472-86BA-718DB5D30038Q38676903-BE1BEE7F-BAF5-43FC-96A1-03350513A557Q38795404-A5A71384-D237-47AD-B6E2-BD6D61CC9C07Q38822415-F0912E9C-0E64-41F7-9A95-B2ACDFBAB7DAQ39337341-5A61587E-2D90-4C24-8EAA-D3FB781052B0Q40067064-7A372A05-6351-4AA4-9172-1D2D73C0E29BQ42373160-18EBA61D-F913-4957-BB4A-CB3DCA55619FQ49593848-44F68F40-C859-4627-A692-B44BF272CC4CQ50014741-C31355F5-1820-4221-9A1B-A989154E04B8
P2860
Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@en
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@nl
type
label
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@en
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@nl
prefLabel
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@en
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@nl
P2093
P50
P1476
Blood and salivary-gland BAFF- ...... in primary Sjögren's syndrome.
@en
P2093
Divi Cornec
Laurent Chiche
Olivier Vittecoq
Pascale Marcorelles
Pierre-Yves Hatron
Sebastian Costa
P304
P356
10.1016/J.JAUT.2015.11.002
P50
P577
2015-12-10T00:00:00Z